Posted on 02/06/2009 in Dental Supplier News Dentsply should be one of the companies to enjoy profitable market conditions over the coming years, despite the current financial downturn, it has been suggested.
The European Markets for Dental Implants, a study conducted by the Millennium Research Group (MRG), implied the industry will grow to be worth over $2.7 billion (1.6 billion pounds) by 2013 from $1.9 billion last year.
New devices ? such as custom-milled abutments - and techniques ? like guided surgery software systems and drilling templates - will enable the sector to expand over the next five years, the study found.
Kevin Flewwelling, manager of MRG's orthopaedics and dental divisions, noted the competitive nature of the implant industry is a major driving force behind investments in research and development.
"Varying levels of technological sophistication - paired against the nature of the competitive landscape and price-sensitivity of these markets - makes for some very surprising results about how some markets will contract while others continue to thrive through this period of economic uncertainty," he remarked.
As well as examining Dentsply, the report also looked at other companies such as Astra Tech, Nobel Biocare and Zimmer Dental.
Products the former currently offers include SmartCem 2, Pre-Sterile Files and QuiXfil.Other news stories from 02/06/2009
Read more in the Zenopa News Archive
How this news is generated
|
